Literature DB >> 13104808

Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency.

G R COATNEY, A S ALVING, R JONES, D D HANKEY, D H ROBINSON, P L GARRISON, W G COKER, W N DONOVAN, A DI LORENZO, R L MARX, I H SIMMONS.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapeutic use; MALARIA

Mesh：

Substances：

Year:  1953        PMID： 13104808

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  19 in total

1.  Primaquine and quinocide as curative agents against sporozoite-induced Chesson strain vivax malaria.

Authors:  G R COATNEY; M E GETZ
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

2.  Prevention and treatment of vivax malaria.

Authors:  J Kevin Baird; Eli Schwartz; Stephen L Hoffman
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

Review 3.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 4.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

5.  Imported malaria.

Authors:  M G Schultz
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

6.  Importation of malaria into the USSR from Afghanistan, 1981-89.

Authors:  V P Sergiev; A M Baranova; V S Orlov; L G Mihajlov; R L Kouznetsov; N I Neujmin; L P Arsenieva; M A Shahova; L A Glagoleva; M M Osipova
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

Review 7.  Unstable vivax malaria in Korea.

Authors:  H I Ree
Journal:  Korean J Parasitol       Date:  2000-09       Impact factor: 1.341

8.  Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.

Authors:  Sophie Uyoga; Alex W Macharia; Carolyne M Ndila; Gideon Nyutu; Mohammed Shebe; Kennedy O Awuondo; Neema Mturi; Norbert Peshu; Benjamin Tsofa; J Anthony G Scott; Kathryn Maitland; Thomas N Williams
Journal:  Blood Adv       Date:  2020-12-08

9.  Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.

Authors:  Brittney M J Potter; Lisa H Xie; Chau Vuong; Jing Zhang; Ping Zhang; Dehui Duan; Thu-Lan T Luong; H M T Bandara Herath; N P Dhammika Nanayakkara; Babu L Tekwani; Larry A Walker; Christina K Nolan; Richard J Sciotti; Victor E Zottig; Philip L Smith; Robert M Paris; Lisa T Read; Qigui Li; Brandon S Pybus; Jason C Sousa; Gregory A Reichard; Sean R Marcsisin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

10.  Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army.

Authors:  Joon-Sup Yeom; Seung-Ho Ryu; Sejoong Oh; Dong-Hyun Choi; Kyoung-Jun Song; Young-Ha Oh; Jae-Hyun Lee; Young-A Kim; Sun-Young Ahn; Hwa-Young Yang; Je-Eun Cha; Jae-Won Park
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.